Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

118.92
Delayed Data
As of Apr 20
 -0.08 / -0.07%
Today’s Change
13.09
Today|||52-Week Range
154.75
+29.56%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-86.2M-68.7M-26.4M-31.2M
 
 
 
 
 
Depreciation673.0K662.0K156.0077.0K
 
 
 
 
 
Total Other Cash Flow7.4M4.3M9.9M3.3M
 
 
 
 
 
Funds From Operations-78.1M-63.7M-16.5M-27.8M
 
 
 
 
 
Funds From/For Other Operating Expenses868.0K7.7M1.1M-5.5M
 
 
 
 
 
Net Cash Flow - Operating Activities-78.9M-71.4M-17.6M-22.3M
 
 
 
 
 
 
InvestingIncrease In Investments-93.8M-117.1M-10.7M-70.2M
 
 
 
 
 
Decrease In Investments85.2M137.2M26.1M48.3M
 
 
 
 
 
Capital Expenditures-144.0K-58.0K-3.1K-125.0K
 
 
 
 
 
Fixed Asset Disposal----697.5K0.00
 
 
Other Investing - Sources0.000.005.8M0.00
 
 
Net Cash Flow Investing-8.8M20.0M22.0M-22.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--8.5M0.00
 
 
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-9.5M-9.3M0.000.00
 
 
 
Net Proceeds Stock Sale94.8M49.6M6.0M173.8M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.00------
Cash Dividends Paid - Total0.000.00------
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing85.3M40.4M14.5M173.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash-2.5M-11.1M18.8M129.5M